Thymosin α1 -: A historical overview

被引:28
作者
Garaci, Enrico [1 ]
机构
[1] Ist Super Sanita, I-00161 Rome, Italy
来源
THYMOSINS IN HEALTH AND DISEASE: FIRST INTERNATIONAL SYMPOSIUM | 2007年 / 1112卷
关键词
thymosin alpha 1; combination therapies;
D O I
10.1196/annals.1415.039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thymosin alpha 1 (T alpha 1), initially isolated from thymus, was characterized by Allan Goldstein in 1977. Since the beginning, our studies were aimed at evaluating its immunomodulating effects when used in combination with cytokines and chemotherapy. Combination therapies have now proved to be effective in inhibiting tumoral growth and in controlling infective diseases especially in the immunocompromised host. More recent studies showed that Tot 1 molecule increased major histocompatibility complex (MHC) class-1 and Toll-like receptor expression as well as cytokine production, suggesting its immunoregulatory role. Overall these results led us to start pilot clinical trials on patients with hepatitis C and cancer.
引用
收藏
页码:14 / 20
页数:7
相关论文
共 22 条
[11]   PREPARATION ASSAY AND PARTIAL PURIFICATION OF A THYMIC LYMPHOCYTOPOIETIC FACTOR (THYMOSIN) [J].
GOLDSTEI.AL ;
SLATER, FD ;
WHITE, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1966, 56 (03) :1010-&
[12]   THYMOSIN-ALPHA-1 - ISOLATION AND SEQUENCE-ANALYSIS OF AN IMMUNOLOGICALLY ACTIVE THYMIC POLYPEPTIDE [J].
GOLDSTEIN, AL ;
LOW, TLK ;
MCADOO, M ;
MCCLURE, J ;
THURMAN, GB ;
ROSSIO, J ;
LAI, CY ;
CHANG, D ;
WANG, SS ;
HARVEY, C ;
RAMEL, AH ;
MEIENHOFER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (02) :725-729
[13]   ROLE OF THYMUS IN DEVELOPMENT OF IMMUNOLOGIC CAPACITY IN RABBITS AND MICE [J].
GOOD, RA ;
PIERCE, JC ;
ARCHER, OK ;
PAPERMASTER, BW ;
MARTINEZ, C ;
DALMASSO, AP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1962, 116 (05) :773-+
[14]   ENHANCEMENT OF IN VIVO INCORPORATION OF LABELED PRECURSORS INTO DNA AND TOTAL PROTEIN OF MOUSE LYMPH NODES AFTER ADMINISTATION OF THYMIC EXTRACTS [J].
KLEIN, JJ ;
GOLDSTEIN, AL ;
WHITE, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1965, 53 (04) :812-+
[15]   THYMOSIN ALPHA-1 MODULATES THE EXPRESSION OF HIGH-AFFINITY INTERLEUKIN-2 RECEPTORS ON NORMAL HUMAN-LYMPHOCYTES [J].
LEICHTLING, KD ;
SERRATE, SA ;
SZTEIN, MB .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1990, 12 (01) :19-29
[16]   BIOCHEMOTHERAPY WITH THYMOSIN-ALPHA-1, INTERLEUKIN-2 AND DACARBAZINE IN PATIENTS WITH METASTATIC MELANOMA - CLINICAL AND IMMUNOLOGICAL EFFECTS [J].
LOPEZ, M ;
CARPANO, S ;
CAVALIERE, R ;
DILAURO, L ;
AMEGLIO, F ;
VITELLI, G ;
FRASCA, AM ;
VICI, P ;
PIGNATTI, F ;
ROSSELLI, M ;
RASI, G ;
GARACI, E .
ANNALS OF ONCOLOGY, 1994, 5 (08) :741-746
[17]   COMBINATION THERAPY WITH THYMOSIN ALPHA-1 POTENTIATES THE ANTITUMOR-ACTIVITY OF INTERLEUKIN-2 WITH CYCLOPHOSPHAMIDE IN THE TREATMENT OF THE LEWIS LUNG-CARCINOMA IN MICE [J].
MASTINO, A ;
FAVALLI, C ;
GRELLI, S ;
RASI, G ;
PICA, F ;
GOLDSTEIN, AL ;
GARACI, E .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (03) :493-499
[18]  
MILLER JF, 1961, LANCET, V2, P748
[19]   ANTITUMOR EFFECT OF COMBINED TREATMENT WITH THYMOSIN ALPHA-1 AND INTERLEUKIN-2 AFTER 5-FLUOROURACIL IN LIVER METASTASES FROM COLORECTAL-CANCER IN RATS [J].
RASI, G ;
SILECCHIA, G ;
SINIBALDIVALLEBONA, P ;
SPAZIANI, E ;
PIERIMARCHI, P ;
SIVILIA, M ;
TREMITERRA, S ;
GARACI, E .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (05) :701-705
[20]   Thymosin α 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling [J].
Romani, L ;
Bistoni, F ;
Gaziano, R ;
Bozza, S ;
Montagnoli, C ;
Perruccio, K ;
Pitzurra, L ;
Bellocchio, S ;
Velardi, A ;
Rasi, G ;
di Francesco, P ;
Garaci, E .
BLOOD, 2004, 103 (11) :4232-4239